Innovative technologies now allow us to probe the genome in more dimensions and at higher resolution than ever before, providing a wealth of information for studying the genomic basis of complex traits. However, meaningful biological insights are often masked by technical artifacts, systematic biases, or low signal-to-noise ratio (“needle in a haystack”). These challenges demand tailored statistical methodology in order to unlock the full potential of emerging assays.
My research group focuses on developing novel frameworks and rigorous inferential procedures that exploit the increased scope and scale of high-throughput sequencing data, with the ultimate goal of uncovering new molecular signals in cancer, child health, and development.
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity
April C. Watt and Paloma Cejas and Molly J. DeCristo and Otto Metzger-Filho and Enid Y. N. Lam and Xintao Qiu and Haley BrinJones and Nikolas Kesten and Rhiannon Coulson and Alba Font-Tello and Klothilda Lim and Raga Vadhi and Veerle W. Daniels and Joan Montero and Len Taing and Clifford A. Meyer and Omer Gilan and Charles C. Bell and Keegan D. Korthauer and Claudia Giambartolomei and Bogdan Pasaniuc and Ji-Heui Seo and Matthew L. Freedman and Cynthia Ma and Matthew J. Ellis and Ian Krop and Eric Winer and Anthony Letai and Myles Brown and Mark A. Dawson and Henry W. Long and Jean J. Zhao and Shom Goel
Transparency and reproducibility in artificial intelligence.
Haibe-Kains B and Adam GA and Hosny A and Khodakarami F and Massive Analysis Quality Control (MAQC) Society Board of Directors and Waldron L and Wang B and McIntosh C and Aerts HJWL
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer
Baca SC and Takeda DY and Seo J and Hwang J and Ku SY and Arafeh R and Arnoff T and Agarwal S and Bell C and O’Connor E and Qiu X and Alaiwi SA and Corona RI and Fonseca MAS and Freedman ML
Author Correction: Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes.
Nuzzo PV and Berchuck JE and Korthauer K and Spisak S and Nassar AH and Alaiwi SA and Chakravarthy A and Shen SY and Bakouny Z and Boccardo F and Steinharter J and Bouchard G and Freedman ML
Prostate cancer reactivates developmental epigenomic programs during metastatic progression.
Pomerantz MM and Qiu X and Zhu Y and Takeda DY and Pan W and Baca SC and Gusev A and Korthauer KD and Severson TM and Ha G and Viswanathan SR and Seo JH and Nguyen HM and Zhang B and Freedman ML
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes.
Nuzzo PV and Berchuck JE and Korthauer K and Spisak S and Nassar AH and Abou Alaiwi S and Chakravarthy A and Shen SY and Bakouny Z and Boccardo F and Steinharter J and Bouchard G and Freedman ML
Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma.
Genetics in medicine : official journal of the American College of Medical Genetics
Lasseter K and Nassar AH and Hamieh L and Berchuck JE and Nuzzo PV and Korthauer K and Shinagare AB and Ogorek B and McKay R and Thorner AR and Lee GM and Braun DA and Bhatt RS and Kwiatkowski DJ
Detection and accurate false discovery rate control of differentially methylated regions from whole genome bisulfite sequencing.
Biostatistics (Oxford, England)
Korthauer K and Chakraborty S and Benjamini Y and Irizarry RA
A practical guide to methods controlling false discoveries in computational biology.
Korthauer K and Kimes PK and Duvallet C and Reyes A and Subramanian A and Teng M and Shukla C and Alm EJ and Hicks SC
A Compositional Model to Assess Expression Changes from Single-Cell Rna-Seq Data
By Xiuyu Ma and Keegan Korthauer and Christina Kendziorski and Michael A. Newton
A practical guide to methods controlling false discoveries in computational biology
Keegan Korthauer and Patrick K Kimes and Claire Duvallet and Alejandro Reyes and Ayshwarya Subramanian and Mingxiang Teng and Chinmay Shukla and Eric J Alm and Stephanie C Hicks
Genome-wide repressive capacity of promoter DNA methylation is revealed through epigenomic manipulation
Keegan Korthauer and Rafael A. Irizarry
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer.
Takeda DY and Spisák S and Seo JH and Bell C and O'Connor E and Korthauer K and Ribli D and Csabai I and Solymosi N and Szállási Z and Stillman DR and Cejas P and Qiu X and Long HW and Freedman ML
High-throughput identification of RNA nuclear enrichment sequences
The EMBO Journal
Chinmay J Shukla and Alexandra L McCorkindale and Chiara Gerhardinger and Keegan D Korthauer and Moran N Cabili and David M Shechner and Rafael A Irizarry and Philipp G Maass and John L Rinn
High-throughput identification of RNA nuclear enrichment sequences
Shukla CJ and McCorkindale AL and Gerhardinger C and Korthauer KD and Cabili MN and Shechner DM and Irizarry RA and Maass PG and Rinn JL
Detection and accurate False Discovery Rate control of differentially methylated regions from Whole Genome Bisulfite Sequencing
Keegan D. Korthauer and Sutirtha Chakraborty and Yuval Benjamini and Rafael A. Irizarry
IPI59: An Actionable Biomarker to Improve Treatment Response in Serous Ovarian Carcinoma Patients
Statistics in Biosciences
Choi, J. and Ye, S. and Eng, K.H. and Korthauer, K. and Bradley, W.H. and Rader, J.S. and Kendziorski, C.
A statistical approach for identifying differential distributions in single-cell RNA-seq experiments.
Korthauer KD and Chu LF and Newton MA and Li Y and Thomson J and Stewart R and Kendziorski C
scDD: A statistical approach for identifying differential distributions in single-cell RNA-seq experiments
Korthauer KD and Chu L and Newton MA and Li Y and Thomson J and Stewart R and Kendziorski C
Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer.
Bodelon C and Vinokurova S and Sampson JN and den Boon JA and Walker JL and Horswill MA and Korthauer K and Schiffman M and Sherman ME and Zuna RE and Mitchell J and Zhang X and Wentzensen N
Limited model antigen expression by transgenic fungi induces disparate fates during differentiation of adoptively transferred T cell receptor transgenic CD4 + T cells: Robust activation and proliferation with weak effector function during recall
Infection and Immunity
Wüthrich, M. and Ersland, K. and Pick-Jacobs, J.C. and Gern, B.H. and Frye, C.A. and Sullivan, T.D. and Brennan, M.B. and Filutowicz, H.I. and O'brien, K. and Korthauer, K.D. and Schultz-Cherry, S. and Klein, B.S.
Predicting Cancer Subtypes Using Survival-Supervised Latent Dirichlet Allocation Models
Advances in Statistical Bioinformatics
Keegan Korthauer and John Dawson and Christina Kendziorski
Unraveling the spatial landscape of epigenomic signals
A common task in the interpretation of epigenomic data, which holds information about the genome not encoded in the DNA sequence itself, is the detection and inference of regions of interest. For example, it is of interest to detect segments of the genome that show significantly higher or lower DNA methylation levels with respect to disease state or developmental stage, as this particular modification to the DNA is known to influence gene regulation. However, the number of possible segments of all possible sizes is near infinite, leading to a massive multiple testing problem. Our group develops tailored statistical and computational approaches for powerful detection and inference of region-based epigenomic signals, while paying particular attention to spatial patterns. We are interested in designing and applying these techniques for the analysis of DNA methylation, histone modification, and chromatin accessibility assay data.
Predicting gene expression from epigenomic signals
It is widely known that epigenetic information, such as DNA methylation and histone modifications, plays a role in gene regulation. However, the prediction of gene expression from epigenomic signals is challenging due to interactions between different epigenomic marks as well as interactions between different regions of the genome. We are working on developing predictive models that account for these challenges and assess the predictive capacity for various epigenomic signals.
Understanding the genomic basis of complex traits
Our group develops computational approaches to study the genomic basis of a variety of complex traits. Our main focus areas currently include modeling the mutation spectrum of cancer genomes, revealing heterogeneity in single-cell gene expression during development, and characterizing the epigenomic landscape of prostate cancer. To maximize impact of our work, we also provide open source computational tools that enable other scientists to make meaningful biological insights.Research Group Members
Ning Shen, Graduate Research Assistant
Marco Tello, Masters Student
Dr. Keegan Korthauer is developing new tools and strategies to enable researchers to sift through large volumes of data and draw more accurate conclusions. We spoke to her about how her work is “separating the signal from the noise.”